This inventor holds 1 USPTO granted patent. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Shamila Nair
Introduction
Shamila Nair is an accomplished inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of enterococcal aminoacyl-tRNA synthetase proteins. Her work has implications for both research and therapeutic applications.
Latest Patents
Shamila Nair holds 1 patent for her invention titled "Enterococcal aminoacyl-tRNA synthetase proteins, nucleic acids and strains comprising same." This patent involves recombinant nucleic acids that encode aminoacyl-tRNA synthetases of enterococcal origin. These nucleic acids can be utilized to create expression constructs and transformed host cells for the production of enterococcal aminoacyl-tRNA synthetases. Additionally, her invention includes antisense nucleic acids that can hybridize to the nucleic acid encoding the aminoacyl-tRNA synthetase of enterococci. The invention also encompasses antibodies that bind to these enzymes, which can be used for purification and study.
Career Highlights
Shamila Nair is currently employed at Cubist Pharmaceuticals, Incorporated, where she continues to advance her research in the field. Her innovative work has positioned her as a key figure in the biotechnology sector, contributing to the understanding and application of tRNA synthetases.
Collaborations
Shamila has collaborated with notable coworkers, including Jianshi Tao and Mandana Sassanfar. These partnerships have further enriched her research and development efforts.
Conclusion
Shamila Nair's contributions to biotechnology through her patent and work at Cubist Pharmaceuticals highlight her role as an influential inventor. Her research on enterococcal aminoacyl-tRNA synthetases opens new avenues for scientific exploration and potential therapeutic applications.